Printer Friendly
The Free Library
5,661,106 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bristol-Myers Seeks Additional Approval for Briplatin.


Tokyo, Japan, July 6, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Bristol-Myers has filed an application for an additional indication of Briplatin Injection, its proprietary anti-tumor agent, with the Ministry of Health, Labor and Welfare.

The company is currently seeking approval for a combination therapy of Briplatin (cisplatin cisplatin /cis·plat·in/ (sis´plat-in) DDP; a platinum coordination complex capable of producing inter- and intrastrand DNA crosslinks; used as an antineoplastic.

cis·plat·in
n.
) and pemetrexed for malignant pleural Pleural
Pleural refers to the pleura or membrane that enfolds the lungs.

Mentioned in: Pneumothorax


pleural

emanating from or pertaining to the pleura.
 mesothelioma Mesothelioma Definition

Mesothelioma is an uncommon disease that causes malignant cancer cells to form within the lining of the chest, abdomen, or around the heart. Its primary cause is believed to be exposure to asbestos.
, a malignant tumor induced by exposure to asbestos.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jul 10, 2006
Words:67
Previous Article:Astellas Pharma, Nippon Boehringer Ingelheim Seek Additional Approval for Micardis.
Next Article:MyVoice Communications Surveys Oral Hygiene.



Related Articles
Bristol-Myers hires project mgr. (Evans International Ltd.) (Brief Article)
Looting the medicine chest: how Bristol-Myers Squibb made off with the public's cancer research.
Two Tower Center is a towering success. (Two Tower Center in East Brunswick, New Jersey)
Developer of Cancer Drug Sues the FDA.(American BioScience Inc.)(Brief Article)
Consumer class actions follow suits by generic drug makers against brand-name companies.
Points of light: Daily award highlights volunteers. (Award Winners).
BUSINESS NOTES CHEROKEE REPORTS RISE IN EARNINGS.(Business)
HMO PROPOSES DRUG DEAL; PAYMENTS TO PUT PRODUCTS ON PREFERRED LIST NOT KICKBACKS, FOUNDATION SAYS.(BUSINESS)
Glancy & Binkow LLP Commences Class Action Lawsuit Against Bristol-Myers Squibb Company.
Biotech has a new home.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles